Serum Interleukin (IL)-15 as a Biomarker of Alzheimer's Disease

Open Access

Peer-reviewed

Research Article

Ram J. Bishnoi ,

* E-mail: bishnoi@uthscsa.edu

Affiliation Department of Psychiatry, University of Texas Health Science Center, San Antonio, Texas, United States of America
⨯
Raymond F. Palmer,

Affiliation Department of Family and Community Medicine, University of Texas Health Science Center, San Antonio, Texas, United States of America
⨯
Donald R. Royall

Affiliation Department of Psychiatry, Family and Community Medicine, and Medicine, University of Texas Health Science Center, South Texas Veterans’ Health System Audie L. Murphy Division, Geriatric Research Education and Clinical Centers, San Antonio, Texas, United States of America
⨯

Reader Comments (0)

Alzheimer's disease
Is the Subject Area "Alzheimer's disease" applicable to this article?

Thanks for your feedback.
Cognitive impairment
Is the Subject Area "Cognitive impairment" applicable to this article?

Thanks for your feedback.
Dementia
Is the Subject Area "Dementia" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Biomarkers
Is the Subject Area "Biomarkers" applicable to this article?

Thanks for your feedback.
Blood-brain barrier
Is the Subject Area "Blood-brain barrier" applicable to this article?

Thanks for your feedback.
Geriatric depression
Is the Subject Area "Geriatric depression" applicable to this article?

Thanks for your feedback.
Microglial cells
Is the Subject Area "Microglial cells" applicable to this article?

Thanks for your feedback.